Browse Category

Dividends 29 November 2025 - 1 December 2025

National Australia Bank (ASX:NAB) Share Price Outlook: 2025 Earnings, Dividends and Fresh Analyst Forecasts

National Australia Bank (ASX:NAB) Share Price Outlook: 2025 Earnings, Dividends and Fresh Analyst Forecasts

National Australia Bank opened December 2025 trading near A$40, about 11% below its October high but well above April lows. FY25 results showed cash earnings flat at A$7.1 billion, with net interest income up 3.8% to A$17.4 billion. Asset quality weakened slightly, with higher credit impairment charges and more non-performing loans. Shares remain up over 20% from April’s trough.
1 December 2025
ANZ Group Holdings (ASX: ANZ) on 1 December 2025: Share Price, Dividend, ESG Shake‑Up and AGM Pay Showdown

ANZ Group Holdings (ASX: ANZ) on 1 December 2025: Share Price, Dividend, ESG Shake‑Up and AGM Pay Showdown

ANZ Group Holdings traded around A$34.20 on Monday afternoon, down about 1% from Friday’s close. The bank reported a statutory profit of A$5.89 billion for FY25, down 10% year-on-year, with revenue up 7% to A$22.2 billion. Investors are weighing a 4.7–4.9% dividend yield, cost cuts, and regulatory penalties. ANZ shares remain up over 20% year-to-date.
1 December 2025
IBM Stock Price Outlook Before the Market Opens on December 1, 2025: AI, Quantum and Dividends Drive NYSE:IBM Near Its Highs

IBM Stock Price Outlook Before the Market Opens on December 1, 2025: AI, Quantum and Dividends Drive NYSE:IBM Near Its Highs

IBM shares closed at $308.58 on Friday, November 28, 2025, up 1.77% on light volume and about 5% below their 52-week high. The stock has gained over 40% in 2025, trading well above key moving averages. Analysts maintain a “Moderate Buy” consensus, with some raising price targets. Institutional holders made small adjustments but largely kept their positions.
McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s shares closed at $311.82 on November 28, 2025, down 0.3%, with a market cap near $223 billion. The stock goes ex-dividend December 1 after a 5% hike to $1.86 per share, implying a forward yield of about 2.4%. Traders expect a mechanical price drop of around $1.86 at Monday’s open. McDonald’s trades at roughly 26 times trailing earnings, above the industry average.
30 November 2025
Opendoor Stock Price Today: OPEN’s AI Pivot, Warrant Dividend and 2026 Forecasts (November 30, 2025)

Opendoor Stock Price Today: OPEN’s AI Pivot, Warrant Dividend and 2026 Forecasts (November 30, 2025)

Opendoor shares closed at $7.70 on November 28, 2025, up over 380% year-to-date after hitting a low of $0.51 in June. The company announced a pivot to AI software, a new CEO, and a special dividend of tradable warrants. Its home-flipping business remains unprofitable, posting a $392 million net loss on $5.15 billion revenue in 2024. Analysts warn of steep downside despite retail-driven stock gains.
Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group closed at $71.62 on Friday, up 0.17%, with volume surging 149% after completing its $13 billion all-stock merger with Interpublic Group. The deal makes Omnicom the world’s largest advertising holding company by revenue. Shares now trade near the bottom of their 52-week range, about 32% below the high. Omnicom is down 17% in 2025 despite a double-digit dividend hike and major balance-sheet moves.
AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength

AbbVie Inc (ABBV) Stock on November 30, 2025: Analyst Downgrade, FDA Wins and Dividend Strength

AbbVie shares closed November at about $227, up 32% year to date but down 3% for the week amid Medicare pricing pressures. The stock’s trailing P/E remains above 170 due to one-off charges, while forward P/E is in the mid-teens. Wall Street Zen downgraded AbbVie from “Strong Buy” to “Buy” on November 30. The average analyst price target sits in the mid-$240s.
30 November 2025
Disney (DIS) Stock News Today, November 30, 2025: Q4 Earnings, Dividend Revival, YouTube TV Deal and New Legal Risks

Disney (DIS) Stock News Today, November 30, 2025: Q4 Earnings, Dividend Revival, YouTube TV Deal and New Legal Risks

Disney stock closed November 28 at $104.47, up 1% and about 16% below its June high. The company reported Q4 revenue of $22.5 billion, flat year-over-year, with GAAP EPS rising to $0.73 from $0.25. Full-year revenue reached $94.4 billion, up 3%. Disney also announced a $1.50 dividend and resumed buybacks.
Exxon Mobil (XOM) Stock: Dividend Hike, Hydrogen Pivot and Climate Lawsuits Define the Late‑2025 Story

Exxon Mobil (XOM) Stock: Dividend Hike, Hydrogen Pivot and Climate Lawsuits Define the Late‑2025 Story

Exxon Mobil shares closed at $115.92 on Nov. 28, near record highs and 4% below the 52-week peak, valuing the company at just under $490 billion. Q3 2025 earnings reached $7.5 billion, with adjusted EPS of $1.88, slightly above analyst forecasts. The company has paused a major hydrogen project and faces new climate-disclosure litigation in California.
30 November 2025
BitMine Immersion Technologies (BMNR) Stock: New CEO, Dividend and 3% of Ethereum Supply After 80% Crash

BitMine Immersion Technologies (BMNR) Stock: New CEO, Dividend and 3% of Ethereum Supply After 80% Crash

BitMine Immersion Technologies closed at $33.12 on November 28, up 4% after heavy Ethereum buying and record earnings. The stock remains volatile, trading between $32.03 and $35.20 on volume of 51.2 million shares. BMNR is down 46% in 30 days but up over 300% in a year. The company now holds 3.63 million ETH and reports $11.2 billion in assets.
30 November 2025
Bristol-Myers Squibb (BMY) Stock on November 29, 2025: 5.4% Dividend, Heavy Institutional Buying and a ‘Hold’ Consensus

Bristol-Myers Squibb (BMY) Stock on November 29, 2025: 5.4% Dividend, Heavy Institutional Buying and a ‘Hold’ Consensus

Bristol-Myers Squibb closed November 28 at $49.20, down 22% from its March high and trailing the S&P 500 by over 30 percentage points year-to-date. The stock’s 5.4% dividend yield drew headlines November 29, as analysts maintained “Hold” ratings and institutional investors quietly increased stakes. Valuation metrics show BMY trading at steep discounts to pharma peers.
30 November 2025
PayPal (PYPL) Stock on November 29, 2025: Big-Money Buying, AI Deals, BNPL Expansion and a New Dividend

PayPal (PYPL) Stock on November 29, 2025: Big-Money Buying, AI Deals, BNPL Expansion and a New Dividend

PayPal shares opened at $62.67 on Nov. 28, 2025, with a market cap in the high $50 billion range and a trailing P/E of 12.5. Norges Bank disclosed a new $921.6 million stake, while Loomis Sayles increased its position. PayPal stock is down 27.5% year-to-date, trading at about half the industry’s average P/E.
Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group (OMC) Stock Today: IPG Mega‑Merger, Dividend Hike and Debt Deal Shape 2026 Outlook

Omnicom Group closed its $13.25 billion all-stock acquisition of Interpublic Group on November 26, forming the world’s largest advertising holding company by revenue. Shares finished November 28 at $71.62, about 32% below their 52-week high. The company also completed a major exchange offer for IPG’s $2.95 billion in senior notes and announced a double-digit dividend increase. Trading remains volatile as investors assess the merger’s impact.
Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

Johnson & Johnson (JNJ) Stock Near Record Highs: Today’s News, Earnings, Dividend and Talc Risks – November 29, 2025

Johnson & Johnson shares closed just above $206 on November 29, 2025, near a record high and pushing the company’s market value to $498 billion. The stock has returned over 40% year-to-date, fueled by earnings beats, a planned orthopedics spin-out, and steady dividend growth. Institutional investors reported mixed moves, with Schroder trimming its stake and New York State Common Retirement Fund also reducing holdings.
1 31 32 33 34 35 39
Go toTop